Precision Medicine

Neurological Disease Study Leads to Precision Medicine Progress

by Erin McNemar, MPA

A new study from the University of Arizona Health Sciences could lead to a breakthrough in the development of precision medicine to prevent neurodegenerative diseases. By studying women on hormone...

Precision Medicine Identifies Those At-Risk of Rapid Kidney Decline

by Erin McNemar, MPA

Researchers using precision medicine discovered signs of rapid decline in kidney function from patients with type 1 diabetes. Diabetes is the leading cause of kidney failure in the United States....

Genomic Analysis Finds Genetic Factors Linked to Severe COVID-19

by Erin McNemar, MPA

Through genomic analysis, researchers have discovered 13 loci, or locations in the human genome, that are strongly associated with infection or severe COVID-19. The team of researchers has also...

Predictive Analytics, Continuous Monitoring Cut Medical Costs by $535K

by Erin McNemar, MPA

Using continuous monitoring and predictive analytics can cut medical costs by nearly $535,000 annually, according to an economic data model from Medtronic. Specifically, continuous pulse oximetry and...

Strategies for Using Predictive Analytics, AI to Improve Care

by Erin McNemar, MPA

As artificial intelligence (AI) technology becomes more interrogated into the medical community, mastering the element of predictive analytics will be a critical component in bettering the quality of...

Using Genomic-Based AI Technology to Advance Cancer Care

by Erin McNemar, MPA

GE Healthcare and SOPHiA GENETICS have signed a letter of intent to collaborate on developing genomic-based artificial intelligence technology to advance cancer care. The goal of the technology is to...

Mayo Clinic Uses Genomics to Understand Neurodevelopmental Disorders

by Erin McNemar, MPA

Researchers at Mayo Clinic have found genetic variants in SPTBN1, a neuro-associated gene, are the reason behind neurodevelopmental disorders. This application of genomics is the first step in...

Genomics Reveals New Path for Chronic Kidney Disease Prevention

by Erin McNemar, MPA

In a new study from Indiana University School of Medicine, a team of researchers and scientists have used genomics to discover alternative ways to treat kidney infections, increasing chronic kidney...

Genetics Gives Insights into Precision Medicine for Mental Health 

by Erin McNemar, MPA

Researchers at Columbia University Vagelos College of Physicians and Surgeons have discovered a possible breakthrough in mental health precision medicine by finding a correlation between a distinct...

AI, Predictive Analytics Pave Way for Premature Baby Care

by Erin McNemar, MPA

Through a Neonatal Artificial Intelligence Morality Score (NAIMS), scientists at James Cook University believe they may have discovered a breakthrough method in keeping premature babies alive....

CRISPR Shows Promise in Gene-Editing Therapy During Clinical Trial

by Erin McNemar, MPA

Scientists at UCL National Amyloidosis Centre at the Royal Free Hospital, London are hoping their gene editing therapy using CRISPR will be a breakthrough for patients suffering from hereditary...

Blood Test Predicts Effectiveness of HPV-Positive Throat Cancer Treatment

by Erin McNemar, MPA

A team of researchers at the University of Michigan Rogel Cancer Center are working on a promising new blood test that they say will be able to predict if patients with metastatic HPV-positive throat...

Data Questions Sepsis Prediction Models, Predictive Analytics 

by Erin McNemar, MPA

In a recent evaluation of Epic Systems’ sepsis prediction model, scientists suggest that the model identifies those at risk of sepsis just 63 percent of the time. This is much lower than the...

New Gene May Help Target Therapies for Intellectual Disabilities

by Erin McNemar, MPA

Researchers at the University of Maryland School of Medicine (UMSOM) have identified a new gene called AP1G1 that could be linked to certain neurodevelopmental disorders and intellectual disabilities,...

Weill Cornell Medicine Launches $1.5B Precision Medicine Campaign

by Jill McKeon

Weill Cornell Medicine announced its $1.5 billion “We’re Changing Medicine” campaign, which intends to advance biomedical innovations in areas such as precision medicine, artificial...

UCLA Receives $4.8M NIH Grant to Improve Genetic Risk Estimates

by Jill McKeon

UCLA Health will receive a $4.8M National Institutes of Health (NIH) grant to improve upon genetic disease risk estimates for diverse populations. The grant will enable researchers to establish...

Eye Protein Biomarkers Show Potential for Precision Medicine

by Jill McKeon

Minimally invasive liquid biopsies can reveal proteomic cancer biomarkers associated with metastatic disease earlier and safer than direct tumor biopsies, showing potential for precision medicine...

Michigan State Cyclotrons to be Used for Precision Medicine

by Jill McKeon

Michigan State University, in partnership with Bold Advanced Medical Future (BAMF Health), announced the arrival of two cyclotrons to be used in the advancement of precision medicine treatments for...

Children’s Hospital LA Awarded $2M for Precision Medicine Study

by Jill McKeon

Children’s Hospital Los Angeles received a three-year, $2 million grant from the state of California to conduct a precision medicine study screening children for adverse childhood experiences...

Precision Medicine for COVID-19 Shows Promise, Needs Improvement

by Jill McKeon

In a recent opinion piece published in JAMA Network, experts explored the use of precision medicine in treating COVID-19 and identified a potential pathway for defining COVID-19 subtypes. The authors...